Amber Thomas-Gordon, MBA, MS

Amber Thomas-Gordon, MBA, MS has a diverse and extensive work experience in the field of clinical research. Amber currently serves as a Clinical Research Manager at Vial, where they manage and supports various aspects of research programs and ensures compliance with guidelines.

Prior to their current role, Amber worked at WCG ThreeWire as a Site Services Specialist and Senior Clinical Research Coordinator. During this time, they conducted chart reviews for a large number of study participants and supported data management needs. Amber also facilitated pre-screening visits for potential study participants.

Before joining WCG ThreeWire, Amber was a Genetic Engineer at MD Anderson Cancer Center, where they led an independent research project and collaborated with multiple laboratory groups to develop and test genetic engineering technology.

Amber also has experience working as a Clinical Research Coordinator at ThreeWire, Inc. and as a Clinical Research Associate at The University of Texas Health Science Center at Houston. In these roles, they managed various aspects of clinical research projects, collected and evaluated research data, and developed Standard Operating Procedures.

Earlier in their career, Amber worked as a Clinical Research Coordinator at Baylor College of Medicine, where they managed the delivery of clinical study protocols and coordinated study activities for a large number of research participants.

Overall, Amber Thomas-Gordon's work experience showcases their expertise in managing and supporting clinical research programs, conducting data analysis, and ensuring compliance with guidelines and regulations.

Amber Thomas-Gordon holds an MBA in Marketing from the University of St. Thomas (TX), which they completed in 2014. Prior to that, they obtained a Bachelor of Science (B.S.) in Biology from Prairie View A&M University in 2007. Amber recently achieved a Master of Science (MS) degree in Biomedical Sciences, specializing in Genetics and Epigenetics, from UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, concluding their studies in 2020.